Clinical trials: Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia

Philadelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia (CML)

Bioequivalence And Food Effect Study Of Bosutinib In Healthy Subjects

• Completed
• Age: 21 to 55 years
• Phase 1

The purpose of this study is to demonstrate the bioequivalence of the clinical tablet formulation (100 mg x 5) to the clinical capsule formulation (100 mg x 5) in healthy subjects under fed condition (Cohort 1) and to investigate…

Trial name

NCT01374139

Testing

Bosutinib

Where

Singapore

Volunteers

88 people, healthy volunteers welcome

Sponsor

Pfizer